Oral antiplatelet and anticoagulant drugs in secondary stroke prevention in Polish patients – Results of lipidogram and lipidogen study

Beata Łabuz-Roszak; Maciej Banach; Michał Skrzypek; Maciej Tomaszewski; D.P. Mikhailidis; Peter P. Tóth; Alberico L. Catapano; Kausik K. Ray; George Howard; Professor Gregory Lip; Fadi J. Charchar; Naweed Sattar; Bryan Williams; Thomas M. MacDonald; Jacek Jerzy Jozwiak

doi:10.1016/j.jns.2019.10.524

Related publications

Article2021

Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study

Beata Łabuz-Roszak, Maciej Banach, Michał Skrzypek, Adam Windak, Tomasz Tomasik, Mirosław Mastej, Maciej Tomaszewski, Dimitri P. Mikhailidis, Peter P. Tóth, Alberico L. Catapano, Kausik K. Ray, George Howard, Professor Gregory Lip, Fadi J. Charchar, Naveed Sattar, Bryan Williams, Thomas M. MacDonald, Peter E. Penson, Jacek Jerzy Jozwiak

Article2023

Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke

Stephanie L. Harrison, Benjamin J. R. Buckley, Deirdre A. Lane, Elnara Fazio‐Eynullayeva, Paula Underhill, Andrew Hill, David J. Werring, Professor Gregory Lip

Article2020

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation

Hans‐Christoph Diener, Graeme J. Hankey, J. Donald Easton, Professor Gregory Lip, Robert G. Hart, Valeria Caso

Article2019

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation

Jiesuck Park, So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Sang‐Bae Ko, Seil Oh, Professor Gregory Lip

Article2015

Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation

Valentina Arnao, Giancarlo Agnelli, Maurizio Paciaroni